PL3853218T3 - Modulatory somatostatyny i ich zastosowania - Google Patents
Modulatory somatostatyny i ich zastosowaniaInfo
- Publication number
- PL3853218T3 PL3853218T3 PL19863395.0T PL19863395T PL3853218T3 PL 3853218 T3 PL3853218 T3 PL 3853218T3 PL 19863395 T PL19863395 T PL 19863395T PL 3853218 T3 PL3853218 T3 PL 3853218T3
- Authority
- PL
- Poland
- Prior art keywords
- somatostatin modulators
- somatostatin
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732735P | 2018-09-18 | 2018-09-18 | |
| PCT/US2019/051514 WO2020061046A1 (en) | 2018-09-18 | 2019-09-17 | Somatostatin modulators and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3853218T3 true PL3853218T3 (pl) | 2025-06-02 |
Family
ID=69772634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19863395.0T PL3853218T3 (pl) | 2018-09-18 | 2019-09-17 | Modulatory somatostatyny i ich zastosowania |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US10696689B2 (pl) |
| EP (2) | EP3853218B1 (pl) |
| JP (1) | JP7431813B2 (pl) |
| AR (1) | AR116424A1 (pl) |
| DK (1) | DK3853218T3 (pl) |
| ES (1) | ES3022912T3 (pl) |
| FI (1) | FI3853218T3 (pl) |
| HR (1) | HRP20250425T1 (pl) |
| HU (1) | HUE071203T2 (pl) |
| LT (1) | LT3853218T (pl) |
| PL (1) | PL3853218T3 (pl) |
| PT (1) | PT3853218T (pl) |
| RS (1) | RS66720B1 (pl) |
| SI (1) | SI3853218T1 (pl) |
| SM (1) | SMT202500155T1 (pl) |
| TW (1) | TWI852944B (pl) |
| WO (1) | WO2020061046A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3484865T3 (pl) | 2016-07-14 | 2023-01-09 | Crinetics Pharmaceuticals, Inc. | Modulatory somatostatyny i ich zastosowania |
| WO2018170284A1 (en) | 2017-03-16 | 2018-09-20 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| WO2019157458A1 (en) | 2018-02-12 | 2019-08-15 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| JP7431813B2 (ja) | 2018-09-18 | 2024-02-15 | クリネティックス ファーマシューティカルズ,インク. | ソマトスタチンモジュレーターとその使用 |
| TWI841768B (zh) | 2019-08-14 | 2024-05-11 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
| SMT202500315T1 (it) | 2020-09-09 | 2025-11-10 | Crinetics Pharmaceuticals Inc | Formulazioni di un modulatore della somatostatina |
| CN117043149A (zh) * | 2021-02-17 | 2023-11-10 | 克林提克斯医药股份有限公司 | 促生长素抑制素调节剂的结晶形式 |
| US20240254106A1 (en) * | 2022-12-13 | 2024-08-01 | Crinetics Pharmaceuticals, Inc. | Somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6127343A (en) * | 1996-05-14 | 2000-10-03 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
| US6025372A (en) | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
| FR2802206B1 (fr) | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| US20060281764A1 (en) | 2005-06-10 | 2006-12-14 | Gaul Michael D | Aminopyrimidines as kinase modulators |
| AU2007309708A1 (en) | 2006-03-13 | 2008-05-02 | Merck Sharp & Dohme Corp. | Somatostatin agonists |
| BRPI0715967A2 (pt) | 2006-08-15 | 2013-08-06 | Hoffmann La Roche | compostos, processo para a sua manufatura, composiÇÕes farmacÊuticas que os compreendem, mÉtodos para o tratamento e/ou prevenÇço de enfermidades que estço associadas com a modulaÇço de receptores de sst do subtipo 5, e uso destes compostos |
| WO2009051705A1 (en) | 2007-10-18 | 2009-04-23 | Merck & Co., Inc. | Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| AU2009262150A1 (en) | 2008-06-25 | 2009-12-30 | Envivo Pharmaceuticals, Inc. | Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors |
| GB0818241D0 (en) | 2008-10-06 | 2008-11-12 | Cancer Res Technology | Compounds and their use |
| EP2473500A2 (en) | 2009-09-01 | 2012-07-11 | Pfizer Inc. | Benzimidazole derivatives |
| GB201008290D0 (en) | 2010-05-18 | 2010-06-30 | Syngenta Ltd | Chemical compounds |
| EP2571356A4 (en) | 2010-05-18 | 2013-11-20 | Merck Sharp & Dohme | SPIROISOXAZOLIN COMPOUNDS AS SSTR5 ANTAGONISTS |
| EP2871179A4 (en) | 2012-07-03 | 2016-03-16 | Ono Pharmaceutical Co | CONNECTION WITH AGONISTIC EFFECT ON THE SOMATOSTATIN RECEPTOR AND ITS USE FOR MEDICAL PURPOSES |
| TWI628175B (zh) | 2013-09-30 | 2018-07-01 | 日商小野藥品工業股份有限公司 | 具有體抑素受體致效活性的化合物及其醫藥用途 |
| US10093795B2 (en) | 2013-10-02 | 2018-10-09 | Kuraray Co., Ltd. | Resin composition, multilayer sheet, packaging material and container |
| PL3484865T3 (pl) | 2016-07-14 | 2023-01-09 | Crinetics Pharmaceuticals, Inc. | Modulatory somatostatyny i ich zastosowania |
| JP6838387B2 (ja) * | 2016-12-21 | 2021-03-03 | トヨタ紡織株式会社 | 内装部品の取付構造 |
| AU2018219644A1 (en) | 2017-02-08 | 2019-08-29 | Ono Pharmaceutical Co., Ltd. | Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof |
| WO2018170284A1 (en) | 2017-03-16 | 2018-09-20 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| WO2019023278A1 (en) | 2017-07-25 | 2019-01-31 | Crinetics Pharmaceuticals, Inc. | MODULATORS OF SOMATOSTATIN AND USES THEREOF |
| WO2019157458A1 (en) | 2018-02-12 | 2019-08-15 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| JP7431813B2 (ja) * | 2018-09-18 | 2024-02-15 | クリネティックス ファーマシューティカルズ,インク. | ソマトスタチンモジュレーターとその使用 |
| TWI841768B (zh) | 2019-08-14 | 2024-05-11 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
-
2019
- 2019-09-17 JP JP2021514532A patent/JP7431813B2/ja active Active
- 2019-09-17 HR HRP20250425TT patent/HRP20250425T1/hr unknown
- 2019-09-17 EP EP19863395.0A patent/EP3853218B1/en active Active
- 2019-09-17 SM SM20250155T patent/SMT202500155T1/it unknown
- 2019-09-17 EP EP25151398.2A patent/EP4548974A3/en active Pending
- 2019-09-17 RS RS20250348A patent/RS66720B1/sr unknown
- 2019-09-17 HU HUE19863395A patent/HUE071203T2/hu unknown
- 2019-09-17 SI SI201930927T patent/SI3853218T1/sl unknown
- 2019-09-17 WO PCT/US2019/051514 patent/WO2020061046A1/en not_active Ceased
- 2019-09-17 US US16/572,921 patent/US10696689B2/en active Active
- 2019-09-17 LT LTEPPCT/US2019/051514T patent/LT3853218T/lt unknown
- 2019-09-17 AR ARP190102640A patent/AR116424A1/es unknown
- 2019-09-17 PT PT198633950T patent/PT3853218T/pt unknown
- 2019-09-17 PL PL19863395.0T patent/PL3853218T3/pl unknown
- 2019-09-17 FI FIEP19863395.0T patent/FI3853218T3/fi active
- 2019-09-17 DK DK19863395.0T patent/DK3853218T3/da active
- 2019-09-17 ES ES19863395T patent/ES3022912T3/es active Active
- 2019-09-17 TW TW108133468A patent/TWI852944B/zh active
-
2020
- 2020-05-19 US US16/877,947 patent/US11186590B2/en active Active
-
2021
- 2021-10-26 US US17/511,326 patent/US20220048924A1/en not_active Abandoned
-
2022
- 2022-04-06 US US17/714,825 patent/US11834462B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE071203T2 (hu) | 2025-08-28 |
| HRP20250425T1 (hr) | 2025-06-20 |
| US20220048924A1 (en) | 2022-02-17 |
| US11186590B2 (en) | 2021-11-30 |
| TW202024095A (zh) | 2020-07-01 |
| US20230022513A1 (en) | 2023-01-26 |
| JP7431813B2 (ja) | 2024-02-15 |
| TWI852944B (zh) | 2024-08-21 |
| AR116424A1 (es) | 2021-05-05 |
| US11834462B2 (en) | 2023-12-05 |
| PT3853218T (pt) | 2025-04-02 |
| EP3853218A4 (en) | 2022-02-16 |
| EP3853218A1 (en) | 2021-07-28 |
| ES3022912T3 (en) | 2025-05-29 |
| US10696689B2 (en) | 2020-06-30 |
| US20200283453A1 (en) | 2020-09-10 |
| LT3853218T (lt) | 2025-05-12 |
| SI3853218T1 (sl) | 2025-06-30 |
| DK3853218T3 (da) | 2025-04-22 |
| EP4548974A3 (en) | 2025-08-13 |
| WO2020061046A1 (en) | 2020-03-26 |
| EP4548974A2 (en) | 2025-05-07 |
| US20200087318A1 (en) | 2020-03-19 |
| JP2022501342A (ja) | 2022-01-06 |
| FI3853218T3 (fi) | 2025-04-15 |
| SMT202500155T1 (it) | 2025-05-12 |
| EP3853218B1 (en) | 2025-02-19 |
| RS66720B1 (sr) | 2025-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269241A (en) | Somatostatin modulators and their uses | |
| ZA201900317B (en) | Somatostatin modulators and uses thereof | |
| ZA202002184B (en) | Adenovirus and uses thereof | |
| IL274219A (en) | Adenovirus and its uses | |
| IL294052B1 (en) | Fluoroalkyl oxadiazoles and their uses | |
| PL3853218T3 (pl) | Modulatory somatostatyny i ich zastosowania | |
| EP3317277A4 (en) | Somatostatin modulators and uses thereof | |
| IL277502A (en) | Compounds and uses for them | |
| ZA202105847B (en) | Mtroc modulators and uses thereof | |
| IL280808A (en) | OX40-binding polypeptides and their uses | |
| EP3317278A4 (en) | Somatostatin modulators and uses thereof | |
| IL277548A (en) | Modulators of caplain and their medicinal uses | |
| IL274220A (en) | Adenovirus and its uses | |
| SG11202006669RA (en) | Peptides and uses thereof | |
| IL287503A (en) | Thio-semicarbazide compounds and their use | |
| IL279483A (en) | Cyanotriazole compounds and their uses | |
| ZA201905513B (en) | Rorgamma modulators and uses thereof | |
| ZA201905511B (en) | Rorgamma modulators and uses thereof | |
| IL273671A (en) | Cornoline variants and their use | |
| IL280369A (en) | Myokines and their uses | |
| HUE068738T2 (hu) | Új szelektív ACKR3-modulátorok és alkalmazásaik | |
| HK40016459A (en) | Rorgamma modulators and uses thereof | |
| HK40016461A (en) | Rorgamma modulators and uses thereof | |
| HK40016442A (en) | Rorgamma modulators and uses thereof | |
| GB201812328D0 (en) | Polypeptides and uses thereof |